Dr. Martina Hirayama
Head of the State Secretariat for Education, Research and Innovation (SERI) at Federal Department of Economic Affairs, Education and Research
Martina Hirayama studied Chemistry at ETH Zurich, the University of Fribourg, and Imperial College London, earning a doctorate in technical sciences from ETH Zurich, where she also pursued postgraduate studies in Business Economics. She led the Polymer Chemistry Group at ETH Zurich and co-founded a start-up in coating technologies, serving as CEO until 2008. At ZHAW, she lectured in Industrial Chemistry, developed the field of polymer materials, and led the Institute of Materials and Process Engineering. From 2011 to 2018, she was Director of the ZHAW School of Engineering and held leadership roles in the Federal Institute of Metrology, Innosuisse, and other key organizations. Since 2019 Prof. Dr. Hirayama has been head of the State Secretariat for Education, Research and Innovation.
Russ Biagio Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing (AI, data science and informatics) to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. Russ Biagio Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing (AI, data science and informatics) to problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. Russ is also the chairperson of the SPHN International Advisory Board.
Antoine Geissbühler is an internist and specialist in medical informatics. A full professor since 2006, he is also Director of the HUG Innovation Centre and Head of the Division of e-Health and Telemedicine, which has been designed as a WHO collaborating centre. His research focuses on the design and application of new IT tools in the medical field. In particular, he helped implement Switzerland's e-health strategy and developed the RAFT project, a major telemedicine network linking hundreds of healthcare professionals in 20 countries in Africa, Asia and Latin America. Antoine is also the chairperson of the SPHN National Advisory Board and the ORD Taskforce Health and Life Science Data.
Anne Lévy
Director-General of the Federal Office of Public Health FOPH (since 2020)
Lic. sc. pol. degree in political science (University of Lausanne), Executive MBA (University of Fribourg)
Anne Lévy coordinates the FOPH’s business with the FDHA’s planning. She assures representation of the FOPH, and in some cases the FDHA, in interdepartmental working groups and on parliamentary committees and international bodies. In addition, Anne Lévy heads and plans healthcare reform projects at the national level.
2015–20 CEO, University Psychiatric Clinics, Basel | 2009–15 Head of Health Protection, Basel-Stadt Department of Health, Basel | 2004–09 Head of Alcohol and Tobacco Section, FOPH, Bern| 2003–04 Technical Assistant to the Assistant Director and Head of the Main Unit Substance Abuse and AIDS, FOPH, Bern | 2001–03 Research Associate, Head of Coordination and Service Platform for Addiction, FOPH, Bern | 2000 Project Manager, United Nations Office for Project Services (UNOPS), New York
Dr. med. Katharina Gasser
General Manager of Roche Pharma Switzerland
Dr. med. Katharina Gasser studied medicine with a specialization in pharmaceutical medicine. She gained practical experience as a doctor in internal medicine and geriatrics and then moved into the healthcare industry, where she worked for many years in various management positions in Switzerland and around the world. Since September 2022 she is the General Manager of Roche Pharma Switzerland.
Dr. Katrin Crameri
Co-head DigiSanté
Federal Department of Home Affairs and co-head of the Digital Transformation division at the Federal Office of Public Health since June 2024. She studied molecular biology in Tübingen, Berlin, and New York, holds a PhD in neuroscience and a Master of Public Health. From 2019 to May 2024, Katrin served as Director of Personalized Health Informatics at the Swiss Institute of Bioinformatics, where she led SPHN’s Data Coordination Center and the BioMedIT project. She is passionate about driving digital transformation in healthcare and dedicated to advancing better research for better health.
